Stavropoulou Elisavet, Ieronymaki Eleftheria, Dimitroulia Evangelia, Constantinidis Theodoros C, Vrioni Georgia, Tsatsanis Christos, Tsakris Athanasios
Department of Microbiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Service of Infectious Diseases, Department of Medicine, Lausanne University Hospital and University of Lausanne (CHUV), 1011 Lausanne, Switzerland.
Microorganisms. 2022 Nov 30;10(12):2374. doi: 10.3390/microorganisms10122374.
Honey has been shown to possess anti-inflammatory and bactericidal properties that may be useful for the prevention and treatment of infections as well as of acute and chronic inflammatory diseases. The antimicrobial potency of honey could be attributed to its physicochemical characteristics combined with the presence of certain compounds, such as hydrogen peroxide and polyphenols. Honey's bacteriostatic or bactericidal capacity varies depending on its composition and the bacterial type of each infection. Nevertheless, not all honey samples possess anti-inflammatory or antibacterial properties and their mechanism of action has not been clearly elucidated. We therefore investigated the anti-inflammatory properties of three different honey samples that derived from different geographical areas of Greece and different botanical origins, namely, arbutus, chestnut, and fir; they were compared to manuka honey, previously known for its anti-inflammatory and antibacterial activity. To test the anti-inflammatory activity of the different samples, we utilized the in vivo model of LPS-driven inflammation, which induces septic shock without the presence of pathogens. To evaluate the antibacterial action of the same honey preparations, we utilized the cecal-slurry-induced peritonitis model in mice. Since acute inflammation and sepsis reduce the biotransformation capacity of the liver, the expression of key enzymes in the process was also measured. The administration of all Greek honey samples to LPS-stimulated mice revealed a potent anti-inflammatory activity by suppressing the TNFα serum levels and the expression of TNFα and iNOS in the liver at levels comparable to those of the manuka honey, but they had no effect on IL-6 or IL-1β. It was shown that the LPS-induced suppression of CYP1A1 in the liver was reversed by Epirus and Crete fir honey, while, correspondingly, the suppression of CYP2B10 in the liver was reversed by Evros chestnut and Epirus fir honey. The effect of the same honey samples in polymicrobial peritonitis in mice was also evaluated. Even though no effect was observed on the disease severity or peritoneal bacterial load, the bacterial load in the liver was reduced in mice treated with Evros chestnut, Epiros fir, and Crete fir, while the bacterial load in the lungs was reduced in Epirus arbutus, Crete fir, and manuka honey-treated mice. Our findings suggest that these specific Greek honey samples possess distinct anti-inflammatory and antibacterial properties, as evidenced by the reduced production of pro-inflammatory mediators and the impaired translocation of bacteria to tissues in septic mice. Their mode of action was comparable or more potent to those of manuka honey.
蜂蜜已被证明具有抗炎和杀菌特性,这可能有助于预防和治疗感染以及急慢性炎症性疾病。蜂蜜的抗菌效力可归因于其理化特性以及某些化合物的存在,如过氧化氢和多酚。蜂蜜的抑菌或杀菌能力因其成分和每种感染的细菌类型而异。然而,并非所有蜂蜜样本都具有抗炎或抗菌特性,其作用机制尚未完全阐明。因此,我们研究了来自希腊不同地理区域、不同植物来源的三种不同蜂蜜样本的抗炎特性,即杨梅蜜、板栗蜜和冷杉蜜;并将它们与以抗炎和抗菌活性而闻名的麦卢卡蜂蜜进行比较。为了测试不同样本的抗炎活性,我们使用了LPS诱导的炎症体内模型,该模型在无病原体的情况下诱导脓毒症休克。为了评估相同蜂蜜制剂的抗菌作用,我们在小鼠中使用了盲肠浆液诱导的腹膜炎模型。由于急性炎症和脓毒症会降低肝脏的生物转化能力,因此还测量了该过程中关键酶的表达。将所有希腊蜂蜜样本给予LPS刺激的小鼠后发现,它们通过抑制TNFα血清水平以及肝脏中TNFα和iNOS的表达,显示出强大的抗炎活性,其水平与麦卢卡蜂蜜相当,但对IL-6或IL-1β没有影响。结果表明伊庇鲁斯和克里特岛冷杉蜜可逆转LPS诱导的肝脏中CYP1A1的抑制,相应地,埃夫罗斯板栗蜜和伊庇鲁斯冷杉蜜可逆转肝脏中CYP2B10的抑制。还评估了相同蜂蜜样本对小鼠多微生物腹膜炎的影响。尽管未观察到对疾病严重程度或腹膜细菌载量有影响,但用埃夫罗斯板栗蜜、伊庇鲁斯冷杉蜜和克里特岛冷杉蜜处理的小鼠肝脏中的细菌载量降低,而用伊庇鲁斯杨梅蜜、克里特岛冷杉蜜和麦卢卡蜂蜜处理的小鼠肺部中的细菌载量降低。我们的研究结果表明,这些特定的希腊蜂蜜样本具有独特的抗炎和抗菌特性,这在脓毒症小鼠中促炎介质产生减少以及细菌向组织的易位受损中得到了证明。它们的作用方式与麦卢卡蜂蜜相当或更强。